Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Hydock, David S ^a   Lien, Chia Ying ^a   Schneider, Carole M ^a   Hayward, Reid ^a  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Echocardiography; Myosin heavy chain; Orchiectomy; Ovariectomy; Sex hormones

Indexed keywords

GOSERELIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; FEMALE; GONADECTOMY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; MALE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; TREADMILL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD FLOW VELOCITY; CASTRATION; DISEASE MODELS, ANIMAL; EXERTION; FEMALE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HYPOGONADISM; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 36849015011     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00801.2007     Document Type: Article

References (85)

1. Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 147: 5967-5974, 2006.
2. Berruti A, Dogliotti L, Terrone C, Cerutti S, Isaia G, Tarabuzzi R, Reimondo G, Mari M, Ardissone P, De Luca S, Fasolis G, Fontana D, Rossetti SR, Angeli A. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 167: 2361-2367, 2002.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Bupha-Intr T, Wattanapermpool J. Cardioprotective effects of exercise training on myofilament calcium activation in ovariectomized rats. J Appl Physiol 96: 1755-1760, 2004.
5. Burnham TR, Wilcox A. Effects of exercise on physiological and psychological variables in cancer survivors. Med Sci Sports Exerc 34: 1863-1867, 2002.
6. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284: H1560-H1569, 2003.
7. Cavasin MA, Tao ZY, Yu AL, Yang XP. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol 290: H2043-H2050, 2006.
8. Chicco AJ, Hydock DS, Schneider CM, Hayward R. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol 100: 519-527, 2006.
9. Chicco AJ, Schneider CM, Hayward R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol 289: R424-R431, 2005.
10. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94: 2614-2619, 1996.
11. Christianson D, Roti E, Vagenakis AG, Braverman LE. The sex-related difference in serum thyrotropin concentration is androgen mediated. Endocrinology 108: 529-535, 1981.
12. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 344: 276-285, 2001.
13. Dunbar SL, Kenney WL. Effects of hormone replacement therapy on hemodynamic responses of postmenopausal women to passive heating. J Appl Physiol 89: 97-103, 2000.
14. Fitzsimons DP, Patel JR, Moss RL. Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 513: 171-183, 1998.
15. Florian M, Freiman A, Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 69: 779-787, 2004.
16. Furr BJ. Pharmacology of the luteinising hormone-releasing hormone (LHRH) analogue, Zoladex. Horm Res 32, Suppl 1: 86-92, 1989.
17. Gadducci A, Biglia N, Sismondi P, Genazzani AR. Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer. Gynecol Endocrinol 20: 343-360, 2005.
18. Gerdes MJ, Dang TD, Lu B, Larsen M, McBride L, Rowley DR. Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1). Endocrinology 137: 864-872, 1996.
19. Golden KL, Marsh JD, Jiang Y, Brown T, Moulden J. Gonadectomy of adult male rats reduces contractility of isolated cardiac myocytes. Am J Physiol Endocrinol Metab 285: E449-E453, 2003.
20. Gorzek JF, Hendrickson KC, Forstner JP, Rixen JL, Moran AL, Lowe DA. Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. Med Sci Sports Exerc 39: 248-256, 2007.
21. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H, Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112, 1997.
22. Haddad F, Masatsugu M, Bodell PW, Qin A, McCue SA, Baldwin KM. Role of thyroid hormone and insulin in control of cardiac isomyosin expression. J Mol Cell Cardiol 29: 559-569, 1997.
23. Hagg U, Andersson I, Naylor AS, Gronros J, Jonsdottir IH, Bergstrom G, Gan LM. Voluntary physical exercise-induced vascular effects in spontaneously hypertensive rats. Clin Sci (Lond) 107: 571-581, 2004.
24. Harkonen P, Torn S, Kurkela R, Porvari K, Pulkka A, Lindfors A, Isomaa V, Vihko P. Sex hormone metabolism in prostate cancer cells during transition to an androgen-independent state. J Clin Endocrinol Metab 88: 705-712, 2003.
25. Herron TJ, Korte FS, McDonald KS. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281: H1217-H1222, 2001.
26. Herron TJ, McDonald KS. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90: 1150-1152, 2002.
27. Hertrampf T, Degen GH, Kaid AA, Laudenbach-Leschowsky U, Seibel J, Di Virgilio AL, Diel P. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med 72: 484-487, 2006.
28. Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 61: 32-38, 2003.
29. Hydock DS, Wonders KY, Schneider CM, Hayward R. Androgen deprivation therapy and cardiac function: effects of endurance training. Prostate Cancer Prostatic Dis 9: 392-398, 2006.
30. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Matsuda M, Yamaguchi I. Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats. Am J Physiol Heart Circ Physiol 286: H1696-H1705, 2004.
31. Jain SK, Rogier K, Prouty L, Jain SK. Protective effects of 17beta-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: relevance to heart disease in postmenopausal women. Free Radic Biol Med 37: 1730-1735, 2004.
32. Jarred RA, Cancilla B, Prins GS, Thayer KA, Cunha GR, Risbridger GP. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 141: 3471-3477, 2000.
33. Jechura TJ, Walsh JM, Lee TM. Testicular hormones modulate circadian rhythms of the diurnal rodent, Octodon degus. Horm Behav 38: 243-249, 2000.
34. Jin B, Conway AJ, Handelsman DJ. Effects of androgen deficiency and replacement on prostate zonal volumes. Clin Endocrinol (Oxf) 54: 437-445, 2001.
35. Jones LC, Bellingham WP, Ward LC. Sex differences in voluntary locomotor activity of food-restricted and ad libitum-fed rats. Implications for the maintenance of a body weight set-point. Comp Biochem Physiol A 96: 287-290, 1990.
36. Katzeff HL, Bovbjerg D, Mark DA. Exercise regulation of triiodothyronine metabolism. Am J Physiol Endocrinol Metab 255: E824-E828, 1988.
37. Kingwell BA, Arnold PJ, Jennings GL, Dart AM. The effects of voluntary running on cardiac mass and aortic compliance in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 16: 181-185, 1998.
38. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89: 591-598, 2001.
39. Konhilas JP, Widegren U, Allen DL, Paul AC, Cleary A, Leinwand LA. Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol 289: H455-H465, 2005.
40. Korte FS, Herron TJ, Rovetto MJ, McDonald KS. Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts. Am J Physiol Heart Circ Physiol 289: H801-H812, 2005.
41. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W. Recommendations for chamber quantification. Eur J Echocardiogr 7: 79-108, 2006.
42. Lekgabe ED, Royce SG, Hewitson TD, Tang ML, Zhao C, Moore XL, Tregear GW, Bathgate RA, Du XJ, Samuel CS. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of non-reproductive organs. Endocrinology 147: 5575-5583, 2006.
43. Liu J, Tsang S, Wong TM. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 147: 4569-4577, 2006.
44. Malhotra A, Buttrick P, Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol Heart Circ Physiol 259: H866-H871, 1990.
45. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98: 256-261, 1998.
46. 2+-activated tension development in single adult cardiac myocytes. Circ Res 84: 1310-1317, 1999.
47. Milne KJ, Thorp DB, Melling CW, Noble EG. Castration inhibits exercise-induced accumulation of Hsp70 in male rodent hearts. Am J Physiol Heart Circ Physiol 290: H1610-H1616, 2006.
48. Moorthy K, Sharma D, Basir SF, Baquer NZ. Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp Gerontol 40: 295-302, 2005.
49. Morris GS, Melton SA, Hegsted M, Bartlett WP. Ovariectomy fails to modify the cardiac myosin isoenzyme profile of adult rats. Horm Metab Res 30: 84-87, 1998.
50. Munoz-Castaneda JR, Montilla P, Munoz MC, Bujalance I, Muntane J, Tunez I. Effect of 17-beta-estradiol administration during adriamycin-induced cardiomyopathy in ovariectomized rat. Eur J Pharmacol 523: 86-92, 2005.
51. Natali AJ, Turner DL, Harrison SM, White E. Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes. J Exp Biol 204: 1191-1199, 2001.
52. Natali AJ, Wilson LA, Peckham M, Turner DL, Harrison SM, White E. Different regional effects of voluntary exercise on the mechanical and electrical properties of rat ventricular myocytes. J Physiol 541: 863-875, 2002.
53. Noble EG, Moraska A, Mazzeo RS, Roth DA, Olsson MC, Moore RL, Fleshner M. Differential expression of stress proteins in rat myocardium after free wheel or treadmill run training. J Appl Physiol 86: 1696-1701, 1999.
54. Nygard R, Norum J, Due J. Goserelin (Zoladex) or orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysis. Anticancer Res 21: 781-788, 2001.
55. Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW. Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity. Endocrinology 144: 230-239, 2003.
56. Paterson AH. Evaluating bone mass and bone quality in patients with breast cancer. Clin Breast Cancer 5, Suppl: S41-S45, 2005.
57. Peng WJ, Yu J, Deng S, Jiang JL, Deng HW, Li YJ. Effect of estrogen replacement treatment on ischemic preconditioning in isolated rat hearts. Can J Physiol Pharmacol 82: 339-344, 2004.
58. Przyklenk K, Groom AC. Effects of exercise frequency, intensity, and duration on revascularization in the transition zone of infarcted rat hearts. Can J Physiol Pharmacol 63: 273-278, 1985.
59. Remmers DE, Cioffi WG, Bland KI, Wang P, Angele MK, Chaudry IH. Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 227: 790-799, 1998.
60. Schaible TF, Malhotra A, Ciambrone G, Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54: 38-49, 1984.
61. Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R. Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment. Cancer 110: 918-925, 2007.
62. Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R. Exercise training manages cardiopulmonary function and fatigue during and following treatment in male cancer survivors. Integr Cancer Ther 6: 235-241, 2007.
63. 2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform. J Physiol 577: 935-944, 2006.
64. Schultz RL, Swallow JG, Waters RP, Kuzman JA, Redetzke RA, Said S, de Escobar GM, Gerdes AM. Effects of excessive long-term exercise on cardiac function and myocyte remodeling in hypertensive heart failure rats. Hypertension 50: 410-416, 2007.
65. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 344: 1997-2008, 2001.
66. Sharkey LC, Holycross BJ, Park S, Shiry LJ, Hoepf TM, McCune SA, Radin MJ. Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF/Mcc-facp rats. J Mol Cell Cardiol 31: 1527-1537, 1999.
67. Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF, Davies JS. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86: 4261-4267, 2001.
68. Smith MR. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer 97: 789-795, 2003.
69. Stone P, Hardy J, Huddart R, A'Hern R, Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36: 1134-1141, 2000.
70. Swenson KK, Henly SJ, Shapiro AC, Schroeder LM. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer. Clin J Oncol Nurs 9: 177-184, 2005.
71. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993.
72. Tanabe K, Masuda K, Hirayama A, Nagase S, Kono I, Kuno S. Effect of spontaneous exercise on antioxidant capacity in rat muscles determined by electron spin resonance. Acta Physiol (Oxf) 186: 119-125, 2006.
73. Taplin ME, Ho SM. Clinical review 134: The endocrinology of prostate cancer. J Clin Endocrinol Metab 86: 3467-3477, 2001.
74. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, Leinwand LA. Expression of the β(slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol 278: H412-H419, 2000.
75. Tatchum-Talom R, Martel C, Marette A. Influence of estrogen on aortic stiffness and endothelial function in female rats. Am J Physiol Heart Circ Physiol 282: H491-H498, 2002.
76. Tekmal RR, Liu YG, Nair HB, Jones J, Perla RP, Lubahn DB, Korach KS, Kirma N. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice. J Steroid Biochem Mol Biol 95: 9-15, 2005.
77. Thomson AA, Timms BG, Barton L, Cunha GR, Grace OC. The role of smooth muscle in regulating prostatic induction. Development 129: 1905-1912, 2002.
78. Vizgirda VM, Wahler GM, Sondgeroth KL, Ziolo MT, Schwertz DW. Mechanisms of sex differences in rat cardiac myocyte response to β-adrenergic stimulation. Am J Physiol Heart Circ Physiol 282: H256-H263, 2002.
79. Wang M, Tsai BM, Kher A, Baker LB, Wairiuko GM, Meldrum DR. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288: H221-H226, 2005.
80. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 60: 6008-6017, 2000.
81. Wattanapermpool J. Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats. Life Sci 63: 955-964, 1998.
82. Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation 100: 1690-1696, 1999.
83. Westendorp IC, Bots ML, Grobbee DE, Reneman RS, Hoeks AP, Van Popele NM, Hofman A, Witteman JC. Menopausal status and distensibility of the common carotid artery. Arterioscler Thromb Vasc Biol 19: 713-717, 1999.
84. Yoshioka J, Node K, Hasegawa S, Paul AK, Mu X, Maruyama K, Nakatani D, Kitakaze M, Hori M, Nishimura T. Impaired cardiac response to exercise in post-menopausal women: relationship with peripheral vascular function. Nucl Med Commun 24: 383-389, 2003.
85. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91: 1154-1160, 1995.